HER2 gene amplification
|
disease |
|
Disease or Syndrome
|
170
|
14
|
0.050 |
None |
1.000 |
5 |
|
2009 |
2019 |
Blood Protein Measurement
|
phenotype |
|
Laboratory Procedure
|
1156
|
2575
|
0.100 |
None |
1.000 |
2 |
2
|
2018 |
2018 |
Lymphocyte Count measurement
|
phenotype |
|
Laboratory Procedure
|
338
|
456
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Alcohol or Other Drugs use
|
disease |
|
Mental or Behavioral Dysfunction
|
108
|
21
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Carcinoma breast stage IV
|
disease |
|
Neoplastic Process
|
573
|
14
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Menstrual spotting
|
phenotype |
|
Sign or Symptom
|
27
|
2
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
pricking of skin
|
phenotype |
|
Sign or Symptom
|
65
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Clostridium; difficile (disorder)
|
disease |
|
Disease or Syndrome
|
106
|
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Malignant transformation
|
phenotype |
|
Neoplastic Process
|
1027
|
20
|
0.010 |
None |
1.000 |
1 |
|
1992 |
1992 |
Birdshot chorioretinopathy
|
disease |
|
Disease or Syndrome
|
15
|
2
|
0.100 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Allergic sensitization
|
disease |
|
Disease or Syndrome
|
85
|
26
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Mammary adenocarcinoma
|
disease |
|
Neoplastic Process
|
29
|
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Human immunodeficiency virus (HIV) II infection category B1
|
disease |
|
Disease or Syndrome
|
985
|
56
|
0.010 |
None |
1.000 |
1 |
|
1990 |
1990 |
Motor neuron atrophy
|
disease |
|
Disease or Syndrome
|
138
|
21
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Blood spots
|
disease |
|
Disease or Syndrome
|
117
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Cardiovascular Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
1756
|
711
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Drug abuse
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
405
|
39
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Congenital chromosomal disease
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Congenital Abnormality
|
757
|
47
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Adenomatous Polyposis Coli
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
609
|
237
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Chorioamnionitis
|
phenotype |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
132
|
2
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Thalassemia
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
136
|
18
|
0.030 |
None |
1.000 |
3 |
|
1992 |
2019 |
beta Thalassemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
198
|
103
|
0.010 |
None |
1.000 |
1 |
|
1992 |
1992 |
Hereditary persistence of fetal hemoglobin thalassemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
35
|
|
0.010 |
None |
1.000 |
1 |
|
1993 |
1993 |
Beta thalassemia intermedia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
37
|
12
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
beta^+^ Thalassemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
156
|
44
|
0.010 |
None |
1.000 |
1 |
|
1992 |
1992 |